Abstract: Due to improved medical care, life expectancy in patients with cystic fibrosis (CF) has veritably improved over the last decades. Importantly, cystic fibrosis related liver disease (CFLD) has become one of the leading causes of morbidity and mortality in CF patients. However, CFLD might be largely underdiagnosed and diagnostic criteria need to be refined. The underlying pathomechanisms are largely unknown, and treatment strategies with proven efficacy are lacking. This review focuses on current invasive and non-invasive diagnostic standards, the current knowledge on the pathophysiology of CFLD, treatment strategies, and possible future developments
International audiencePURPOSE OF REVIEW: Cystic fibrosis (CF; OMIM 219700) is caused by variations i...
ObjectiveCystic fibrosis associated liver disease (CFLD) is the third largest cause of mortality in ...
Incidence of liver disease (LD) associated with cystic fibrosis (CF) and its clinical characterizati...
Due to improved medical care, life expectancy in patients with cystic fibrosis (CF) has veritably im...
Cystic fibrosis-associated liver disease (CFLD) affects ca. 30 % of patients. The CFLD is now consid...
Purpose of review To provide an insight and overview of the challenges in the diagnosis, follow-up a...
PURPOSE OF REVIEW: This review highlights recent developments in liver disease associated with cysti...
The survival of patients with cystic fibrosis (CF) has progressively increased over recent decades, ...
OBJECTIVES: Hepatobiliary complications are a leading cause of morbidity and mortality in cystic fib...
Objectives: Hepatobiliary complications are a leading cause of morbidity and mortality in cystic fib...
Objectives: Hepatobiliary complications are a leading cause of morbidity and mortality in cystic fib...
Cystic Fibrosis-related Liver Disease (CFLD) is highly prevalent in the first decade of life. Nearly...
Cystic Fibrosis-related liver disease (CFLD) has become a leading cause of morbidity and mortality i...
ObjectiveCystic fibrosis associated liver disease (CFLD) is the third largest cause of mortality in ...
AbstractApproximately 5–10% of cystic fibrosis (CF) patients develop multilobular cirrhosis during t...
International audiencePURPOSE OF REVIEW: Cystic fibrosis (CF; OMIM 219700) is caused by variations i...
ObjectiveCystic fibrosis associated liver disease (CFLD) is the third largest cause of mortality in ...
Incidence of liver disease (LD) associated with cystic fibrosis (CF) and its clinical characterizati...
Due to improved medical care, life expectancy in patients with cystic fibrosis (CF) has veritably im...
Cystic fibrosis-associated liver disease (CFLD) affects ca. 30 % of patients. The CFLD is now consid...
Purpose of review To provide an insight and overview of the challenges in the diagnosis, follow-up a...
PURPOSE OF REVIEW: This review highlights recent developments in liver disease associated with cysti...
The survival of patients with cystic fibrosis (CF) has progressively increased over recent decades, ...
OBJECTIVES: Hepatobiliary complications are a leading cause of morbidity and mortality in cystic fib...
Objectives: Hepatobiliary complications are a leading cause of morbidity and mortality in cystic fib...
Objectives: Hepatobiliary complications are a leading cause of morbidity and mortality in cystic fib...
Cystic Fibrosis-related Liver Disease (CFLD) is highly prevalent in the first decade of life. Nearly...
Cystic Fibrosis-related liver disease (CFLD) has become a leading cause of morbidity and mortality i...
ObjectiveCystic fibrosis associated liver disease (CFLD) is the third largest cause of mortality in ...
AbstractApproximately 5–10% of cystic fibrosis (CF) patients develop multilobular cirrhosis during t...
International audiencePURPOSE OF REVIEW: Cystic fibrosis (CF; OMIM 219700) is caused by variations i...
ObjectiveCystic fibrosis associated liver disease (CFLD) is the third largest cause of mortality in ...
Incidence of liver disease (LD) associated with cystic fibrosis (CF) and its clinical characterizati...